Explore Potential Personalized Cancer Vaccine Cost Categories
Personalized cancer vaccines -- also called neoantigen vaccines -- are investigational immunotherapies designed from sequencing data from a patient's tumor. There is no universal price. JLF currently publishes one peptide-vaccine expanded-access model of roughly $92,000 before treating-physician administration, with administration listed separately at approximately $7,000-$25,000. Other trials, sponsors, platforms, institutions, and insurance decisions can differ.
Potential cost categories can include tumor and healthy-tissue sequencing, neoantigen identification, GMP manufacturing, shipping, administration, monitoring, travel, and related clinical care. The adjustable values below are educational modeling inputs, not verified quotes or typical prices for every pathway.
In a clinical trial, a sponsor may cover the investigational product or certain research-related services, but patients can still face clinical-care, travel, lodging, insurance, or other expenses. Expanded-access programs may use FDA-authorized cost recovery. Confirm every charge, refund rule, and coverage decision directly with the treating institution, sponsor or program, and insurer.
Use the calculator below to explore how different cost categories affect a total. It does not determine eligibility, coverage, treatment cost, or financial suitability.
Illustrative input only. Testing scope, institution, billing, and coverage vary.
Design services and whether they are billed separately vary by program.
Platform, batch, release testing, sponsor, and program can change manufacturing costs.
Administration and dose schedules vary. JLF currently publishes a seven-dose protocol.
Monitoring tests, duration, clinical billing, and research coverage are protocol-specific.
Illustrative professional and institutional coordination category; not an FDA fee quote.
Illustrative Model Total
$105,000
Not a quote, coverage decision, or recommendation to borrow. Verify every applicable charge in writing.
Cost Breakdown
Estimates are approximate and vary by provider, location, and individual case. This is not a quote or financial guarantee. Always verify costs directly with your care team.
Provider & Approach Comparison
| Provider / Approach | Published / Illustrative Amount | Timeline | Notes |
|---|---|---|---|
| Illustrative multi-provider pathway | Varies | Varies | Sequencing, design, manufacturing, administration, and monitoring may be provided and billed by different organizations |
| Jaime Leandro Foundation (JLF) | ~$92,000 before administration | ~4–5 months from sequencing receipt to delivery | JLF-specific published peptide-vaccine model; administration currently listed separately at ~$7,000–$25,000 |
| Clinical Trial (if eligible) | Varies | Varies | A sponsor may cover the investigational product or research services; other clinical, travel, lodging, or insurance costs may remain |
| Academic Medical Center | Varies widely | Varies | Programs, trial status, services, eligibility, and costs must be checked directly with the institution |
JLF figures reflect its public FAQ checked July 2026. All other pathways vary. This table is educational and is not a quote, coverage decision, or treatment recommendation.
Financial Questions to Check
Investigational care can create large and uncertain costs. Verify coverage and charges before committing funds, and seek independent advice before borrowing.
Borrowing
Loan rates, fees, promotional terms, and eligibility change. Compare current written offers and consider independent financial advice before borrowing for an investigational treatment.
Cancer Financial Assistance
Some nonprofit and hospital programs help with defined cancer-related expenses, but eligibility and covered costs vary. Ask a hospital financial navigator and verify terms directly with each organization.
Clinical Trial Enrollment
A trial sponsor may cover the investigational product or research-related services. Eligibility, recruiting status, covered expenses, travel, and ordinary clinical-care costs vary by trial and location. Confirm details with the study team.
HSA & FSA Accounts
Do not assume an investigational treatment or related expense is HSA/FSA-eligible. Ask the plan administrator or a qualified tax adviser which documented expenses, if any, qualify.
Crowdfunding
Some families consider community fundraising. Results are unpredictable, privacy tradeoffs are real, and fundraising should not be treated as guaranteed financing.
Combination Approach
Before borrowing or committing funds, get a written, current breakdown of program charges, treating-physician fees, refund rules, travel, monitoring, and possible covered services. Consider independent financial guidance for a commitment this large.
Follow the Research
Get careful updates on personalized cancer vaccines, clinical trials, and expanded access. The calculator stays in your browser and does not collect the values you select.
Subscribe for UpdatesMedical Disclaimer: The calculator and newsletter do not establish a doctor-patient relationship. ImmunaPath provides educational information, not medical diagnosis, treatment, financial advice, or guaranteed pricing.